Company: LNAI
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001731122-25-001544
Chunk: 3

Company: Lunai Bioworks Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 3
---
,096,166

—

—

2,096,181

Restricted shares issued for services rendered

200,000

200

1,399,980

—

—

1,400,000

Forfeited shares of common stock

(83,333
)

(8
)

8

—

—

—

Stock-based compensation

—

—

357,648

—

—

357,648

Net loss

—

—

—

(44,212,036
)

—

(44,212,036
)

Foreign currency translation adjustment

—

—

—

—

6,468,061

6,468,061

September 30, 2024

16,104,277

$
1,610

$
468,455,289

$
(376,667,117
)
 
$
6,297,215

$
98,086,998

June 30, 2025

17,739,291

1,774

$
478,296,114

(510,462,570
)

10,814,842

(21,349,841
)

Issuance of common stock pursuant to conversion of convertible notes

5,355,809

536

16,066,892

—

—

16,067,427

Issuance of common stock pursuant to settlement of accounts payable

85,147

9

184,300

—

—

184,308

Stock-based compensation

—

—

181,312

—

—

181,312

Shares added for fractional shares pursuant to reverse stock split

30

—

—

—

—

—

Net income

—

—

—

2,819,021

—

2,819,021

Foreign currency translation adjustment

—

—

—

—

(10,943,003
)

(10,943,003
)

September 30, 2025

23,180,277

$
2,318

$
494,728,618

$
(507,643,549
)
 
$
(128,161
)
 
$
(13,040,774
)

See accompanying notes to the unaudited condensed consolidated
financial statements.

5

LUNAI BIOWORKS INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)

For the Three Months Ended

September 30,

2025
 
2024

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income (loss)
 
$
2,819,021

$
(44